Li, Z., Qian, J., Li, J., & Zhu, C. (2019). Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway. Exp Ther Med.
Citação norma ChicagoLi, Zhixiang, Jun Qian, Jing Li, and Chao Zhu. "Knockdown of LncRNA-HOTAIR Downregulates the Drug-resistance of Breast Cancer Cells to Doxorubicin Via the PI3K/AKT/mTOR Signaling Pathway." Exp Ther Med 2019.
Citação norma MLALi, Zhixiang, Jun Qian, Jing Li, and Chao Zhu. "Knockdown of LncRNA-HOTAIR Downregulates the Drug-resistance of Breast Cancer Cells to Doxorubicin Via the PI3K/AKT/mTOR Signaling Pathway." Exp Ther Med 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.